Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
about
Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisThe Role of Astrocytes in Multiple Sclerosis ProgressionLactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interactionIonic regulation of cell volume changes and cell death after ischemic stroke.Age-related changes of myelin basic protein in mouse and human auditory nerve.Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Reduced creatine kinase B activity in multiple sclerosis normal appearing white matterWallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.In vivo evidence of glutamate toxicity in multiple sclerosis.Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.Tyrosine phosphorylation of GluK2 up-regulates kainate receptor-mediated responses and downstream signaling after brain ischemiaMechanisms of axonal injury: internodal nanocomplexes and calcium deregulation.Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucomaAxoplasmic reticulum Ca(2+) release causes secondary degeneration of spinal axons.Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model.Roles of white matter in central nervous system pathophysiologies.Neuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injuryTherapeutic potential of kainate receptors.Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.The Influence of Glutamate on Axonal Compound Action Potential In Vitro.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Glutamate and ATP signalling in white matter pathology.Cannabinoids, multiple sclerosis and neuroprotection.White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosisMultiple sclerosis: Prospects and promise.Relapsing and progressive forms of multiple sclerosis: insights from pathology.Neurotransmitter signaling in white matter.In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptorsAxons get excited to death.Identification of four functional NR3B isoforms in developing white matter reveals unexpected diversity among glutamate receptors.The axonal endoplasmic reticulum: One organelle-many functions in development, maintenance, and plasticity.Changes in inhibitory CA1 network in dual pathology model of epilepsy.Functional ionotropic glutamate receptors on peripheral axons and myelin.Learning new tricks from an old dog: using experimental autoimmune encephalomyelitis to study comorbid symptoms in multiple sclerosis.
P2860
Q26744629-742B0DE7-8DB5-4378-8ACC-478419BD89E5Q26782843-D03D2311-53C1-4D44-B2CB-9A0E56094A4BQ26851808-6CAE136C-C1E3-45F8-BA12-758C984806AFQ27691821-84544FC7-96AE-4C77-B93C-3833BB286DA7Q30468649-1BF57152-A1BA-4B1B-95BE-5AA884BCB63BQ30988577-25FC7EAC-4C64-4C81-B86A-0EDC7A086805Q31139925-2B3E439D-DF0F-4F32-8C51-DBBEC74D7B94Q33593127-C1BAFAEC-D804-4351-8B8D-E0FB0F384F64Q33657315-CA596206-C4BB-4135-968C-4435A042A628Q34081836-74A4FB86-E4C3-4D56-9EDD-6198D2E2B98AQ34213029-BB1786D1-AB69-4F1B-AC42-65478CBE1E32Q34281155-614539C3-D263-46DA-9505-D68BB0A8CD6DQ34292220-4F37B864-C9A7-4689-9249-10EC50C760C0Q34344447-9B508EEB-591A-4ED2-9217-F86E9AC00ABAQ34470829-4D6CF124-50D6-4E41-854A-FFFFD2026D0AQ35084174-94E29A7D-B5A8-4779-B364-E1CE086CE9DEQ35772761-437BBADF-AC9F-4D0F-849B-524EF4332580Q35846494-20FDFD39-1604-421D-A553-03F64722F5A3Q36095115-62ED172C-4A4D-4C4A-B7BB-4C371976419CQ36199193-F4F5FA67-5B77-434F-A6BF-9C61E256EDF1Q37438390-142C5EEF-E6BB-4E42-A27D-2A91DA847763Q37495099-76C66F9E-6C83-432C-A4C0-3BB19CA61631Q37800214-A0891B55-5AFD-4918-9832-9D424715E346Q37830727-1A52A80D-B135-4D3D-AD6F-BD8B0BAC585EQ37960199-045E94E1-0F01-4319-BEB1-5AC9B40D8DF3Q37972980-379C806C-0251-445F-9265-02C8E738D9D3Q38129775-664F4FA4-41D0-43BA-A6FF-8EF0B7D4446FQ38203770-F87050DB-13C0-4DB6-A049-6C0A62CE4C2DQ38206164-098764F0-3CC1-4C38-B566-1CE1FCA82562Q40217021-A42CE1CF-6D51-4E39-9F2B-981BD023A86AQ41612066-0BE24CB0-9A7A-48A1-8864-085DF28D7797Q42913988-3A7E0AE5-2493-48FA-8ACC-1763B2CB1671Q44172013-20483245-3A8F-4505-B21B-1AA031264180Q47405859-6598AA4A-4C5A-49EA-AE1F-1E45E0D5F903Q48637007-88C671BB-0477-4E5F-AFB4-9AB3416AD29AQ48910324-9D3E3DE8-CB1B-468B-ADB2-EDAF7DAB8779Q51849231-BE4E9F66-A56E-4B9F-9DAA-6869289F1EDA
P2860
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
@ast
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
@en
type
label
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
@ast
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
@en
prefLabel
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
@ast
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
@en
P2093
P2860
P356
P1433
P1476
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
@en
P2093
Ajoy Basak
Andrew Chen
Bruce D Trapp
Elaine Coderre
Mohamed Ouardouz
Peter K Stys
Renata Rehak
Shameed Hameed
Xinghua Yin
P2860
P304
P356
10.1002/ANA.21533
P577
2009-02-01T00:00:00Z